Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Fabris, E; Selvarajah, A; Tavenier, A; Hermanides, R; Kedhi, E; Sinagra, G; Van't Hof, A

Van't Hof, A (通讯作者),Zuyderland Med Ctr, Dept Cardiol, Heerlen, Netherlands.;Van't Hof, A (通讯作者),Maastricht Univ Med, Dept Cardiol, Maastricht, Netherlands.;Van't Hof, A (通讯作者),Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (5): 463

Abstract

Antithrombotic therapy is the cornerstone of pharmacological treatment in patients undergoing primary percutaneous coronary intervention (PCI). Howeve......

Full Text Link